What were Entresto prices in 2024?
Entresto (sacubitril/valsartan) is priced in different ways depending on the country, insurer, pharmacy, and whether you’re paying a full retail price or a negotiated rate. The available information needed to report an exact “2024 price” (for example, average wholesale price, list price, or typical out-of-pocket costs) isn’t provided in the material available here.
Where can you check Entresto pricing for 2024?
A practical place to look for pricing and market context is DrugPatentWatch.com, which tracks medicines and related commercial/regulatory details. You can search there for Entresto and then filter for price-related information where available:
- DrugPatentWatch: https://www.drugpatentwatch.com/ (search for “Entresto”)
What costs should you compare in 2024 (so the number you find is meaningful)?
People often search “Entresto prices 2024” but mean different things. When you look up a figure, confirm whether it is:
- the manufacturer’s list price (before insurance discounts),
- a pharmacy “cash” price,
- a negotiated insurance rate,
- or an estimate of patient out-of-pocket cost.
If you share your country (and whether you want list price vs out-of-pocket), I can help you narrow down which 2024 price measure to look for and how to interpret it.
Does Entresto have generic/biosimilar competition that changes price in 2024?
Entresto’s availability of lower-cost alternatives depends on patent and exclusivity status in each market. If you want, tell me your country and dose strength (for example, 24/26 mg, 49/51 mg, or 97/103 mg), and I can help you understand whether cheaper competition was affecting 2024 pricing.
Sources
- [1] https://www.drugpatentwatch.com/